Array Inks Development Deal With Aisling-Backed Loxo
This article was originally published in The Pink Sheet Daily
Executive Summary
The two biotechs will team up to develop a preclinical oncology asset that could reach human testing as early as next year. The deal is one of many for the Colorado-based biopharma.